Author

J. Class

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:mouse· 4 Assay:proteomics· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

P. Penaloza-MacMaster· 3 shared T. Dangi· 3 shared J. M. Richner· 2 shared J. Richner· 2 shared S. Sanchez· 2 shared A. Dickson· 1 shared A. K. Pinto· 1 shared E. Geerling· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

P. Penaloza-MacMaster

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Nucleocapsid-specific humoral responses improve the control of SARS-CoV-2

T. Dangi, S. Sanchez, M. Park, J. Class, M. C. Richner, J. M. Richner, P. Penaloza-MacMaster

This study shows that nucleocapsid-specific antibodies can help control SARS-CoV-2 infection in mice, suggesting their potential inclusion in vaccines and monoclonal therapies.

bioRxiv · Mar 9, 2022 · PreprintImmunology

SARS coronavirus vaccines protect against different coronaviruses

T. Dangi, N. Palacio, S. Sanchez, J. Class, L. Visvabharathy, T. Ciucci, I. Koralnik, J. Richner, P. Penaloza-MacMaster

This study shows SARS-CoV-2 vaccines and prior coronavirus infections generate cross-reactive antibodies and T cell responses that provide protection against other coronaviruses in humans and mice.

bioRxiv · Jun 1, 2021 · PreprintImmunology

A SARS CoV-2 nucleocapsid vaccine protects against distal viral dissemination

J. Class, T. Dangi, J. Richner, P. Penaloza-MacMaster

This study shows that including the nucleocapsid antigen in SARS CoV-2 vaccines improves protection against viral spread to the brain.

bioRxiv · Apr 26, 2021 · PreprintImmunology

mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2

M. Hassert, E. Geerling, E. T. Stone, T. L. Steffen, A. Dickson, M. S. Feldman, J. Class, J. M. Richner, J. D. Brien, A. K. Pinto

This study uses mRNA to express human ACE2 in mice to study SARS-CoV-2 adaptive immune responses, finding enhanced T cell responses but no antibody enhancement.

bioRxiv · Aug 7, 2020Immunology